Value Evaluation of Quantitative Aspergillus fumigatus-Specific IgG Antibody Test in the Diagnosis of Non-neutropenic Invasive Pulmonary Aspergillosis
- PMID: 38803521
- PMCID: PMC11129758
- DOI: 10.2147/IDR.S460513
Value Evaluation of Quantitative Aspergillus fumigatus-Specific IgG Antibody Test in the Diagnosis of Non-neutropenic Invasive Pulmonary Aspergillosis
Abstract
Background: The role of Aspergillus-specific IgG antibody test in the diagnosis of non-neutropenic invasive pulmonary aspergillosis (IPA) is still uncertain, and related studies are also limited.
Purpose: This study aims to evaluate the quantitative test value of Aspergillus fumigatus-specific IgG antibody in non-neutropenic IPA, which could provide additional evidence for related clinical diagnosis.
Methods: This prospective study collected clinical data of suspected IPA patients from January, 2020 to December, 2022, and patients were divided into two groups, IPA and non-IPA. The study analyzed clinical characteristics and diagnostic value of Aspergillus-specific IgG antibody test, using the receiver operating characteristic (ROC) curve to evaluate diagnostic efficacy.
Results: The study enrolled 59 IPA cases and 68 non-IPA cases, the average admission age of IPA group was 63.2±9.6 (33-79), and the gender ratio (male:female) of IPA group was 42:17. The proportion of patients with history of smoking and COPD were higher in IPA group (59.3% vs 39.7%, P=0.027; 33.9% vs 14.7%, P =0.011, respectively). The level of Aspergillus fumigatus-specific IgG antibody in IPA group was significantly higher than non-IPA group (202.1±167.0 vs 62.6±58.0, P<0.001). The area under the ROC curve was 0.799 (95%CI: 0.718, 0.865 P<0.001), and the cut-off with best diagnostic efficacy was 91 AU/mL.
Conclusion: Immunological test plays an important role in the diagnosis of pulmonary aspergillosis, and Aspergillus-specific IgG antibody test has the good diagnostic value in non-neutropenic IPA.
Keywords: Aspergillus; IgG; diagnosis; invasive pulmonary aspergillosis; non-neutropenic.
© 2024 Sheng et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures



Similar articles
-
Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients.BMC Pulm Med. 2020 Apr 15;20(1):89. doi: 10.1186/s12890-020-1125-y. BMC Pulm Med. 2020. PMID: 32293386 Free PMC article.
-
The clinical value of Aspergillus-specific IgG antibody test in the diagnosis of nonneutropenic invasive pulmonary aspergillosis.Clin Microbiol Infect. 2023 Jun;29(6):797.e1-797.e7. doi: 10.1016/j.cmi.2023.02.002. Epub 2023 Feb 10. Clin Microbiol Infect. 2023. PMID: 36773771
-
Evaluation of the Dynamiker Quantitative Anti-Aspergillus Fumigatus Specific Detection for the Diagnosis of Different Kinds of Chronic Pulmonary Aspergillosis.Infect Drug Resist. 2024 Sep 25;17:4175-4184. doi: 10.2147/IDR.S479714. eCollection 2024. Infect Drug Resist. 2024. PMID: 39347489 Free PMC article.
-
LDBio Aspergillus immunochromatographic test lateral flow assay for IgG/IgM antibody detection in chronic pulmonary aspergillosis: Single-centre evaluation and meta-analysis.Indian J Med Microbiol. 2022 Apr-Jun;40(2):204-210. doi: 10.1016/j.ijmmb.2022.03.002. Epub 2022 Apr 1. Indian J Med Microbiol. 2022. PMID: 35370006
-
Advances in the In Vivo Molecular Imaging of Invasive Aspergillosis.J Fungi (Basel). 2020 Dec 4;6(4):338. doi: 10.3390/jof6040338. J Fungi (Basel). 2020. PMID: 33291706 Free PMC article. Review.
Cited by
-
Sensitivity of serum galactomannan antigen in the diagnosis of invasive aspergillosis in patients with obstructive pulmonary diseases (asthma and chronic obstructive pulmonary diseases).Postepy Dermatol Alergol. 2024 Nov 21;42(2):183-189. doi: 10.5114/ada.2024.145208. eCollection 2025 Apr. Postepy Dermatol Alergol. 2024. PMID: 40521067 Free PMC article.
-
Evaluation of a novel aspergillus IgG lateral flow assay for the diagnosis of non-neutropenic patients with acute and subacute invasive aspergillosis.Front Cell Infect Microbiol. 2025 Jun 20;15:1599425. doi: 10.3389/fcimb.2025.1599425. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40621162 Free PMC article.
-
Non-invasive monitoring of Aspergillus infections in chronic lung disease patients: a combined serology and HRCT imaging approach.Front Cell Infect Microbiol. 2025 Jun 27;15:1494522. doi: 10.3389/fcimb.2025.1494522. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40654578 Free PMC article.
References
-
- Hospenthal DR, Kwon-Chung KJ, Bennett JE. Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med Mycol. 1998;36(3):165–168. - PubMed
LinkOut - more resources
Full Text Sources